Rigel Pharma (RIGL) Misses Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $34.01 +3.34%
Financial Fact:
Total costs and expenses: 26.5M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Financial Fact:
Total costs and expenses: 26.5M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Rigel Pharma (NASDAQ: RIGL) reported Q1 EPS of ($0.13), $0.01 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $3.58 million versus the consensus estimate of $3.33 million.
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AeroVironment restates quarterly financials, citing $89M goodwill error
- Morgan Stanley sees little room left in steel rally, cuts Cleveland-Cliffs rating
- Stifel Reiterates Buy Rating on FedEx (FDX) Ahead of Q4 Earnings
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
